CORT Joseph Douglas Lyon sells $285K worth of shares
Jul 22, 2025, 4:35 AM
0.00%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
Joseph Douglas Lyon sold 3,877 shares of CORT on 17 July at $73.48 per share, worth a total of $285K. They now own 10,066 CORT shares, or a 28% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
